367 related articles for article (PubMed ID: 29628274)
1. Macrophage-Targeted Therapeutics for Metabolic Disease.
Peterson KR; Cottam MA; Kennedy AJ; Hasty AH
Trends Pharmacol Sci; 2018 Jun; 39(6):536-546. PubMed ID: 29628274
[TBL] [Abstract][Full Text] [Related]
2. Targeted drug delivery to macrophages.
Jain NK; Mishra V; Mehra NK
Expert Opin Drug Deliv; 2013 Mar; 10(3):353-67. PubMed ID: 23289618
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of NK007 to macrophages to treat colitis.
Chen S; Wang J; Cheng H; Guo W; Yu M; Zhao Q; Wu Z; Zhao L; Yin Z; Hong Z
J Pharm Sci; 2015 Jul; 104(7):2276-84. PubMed ID: 25964181
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery to macrophages: Challenges and opportunities.
Pei Y; Yeo Y
J Control Release; 2016 Oct; 240():202-211. PubMed ID: 26686082
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological targets of metabolism in disease: Opportunities from macrophages.
Castegna A; Gissi R; Menga A; Montopoli M; Favia M; Viola A; Canton M
Pharmacol Ther; 2020 Jun; 210():107521. PubMed ID: 32151665
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue macrophage in immune regulation of metabolism.
Qiu Y; Shan B; Yang L; Liu Y
Sci China Life Sci; 2016 Dec; 59(12):1232-1240. PubMed ID: 27837402
[TBL] [Abstract][Full Text] [Related]
7. Tissue-Resident and Recruited Macrophages in Primary Tumor and Metastatic Microenvironments: Potential Targets in Cancer Therapy.
Cotechini T; Atallah A; Grossman A
Cells; 2021 Apr; 10(4):. PubMed ID: 33924237
[TBL] [Abstract][Full Text] [Related]
8. Loss of macrophage fatty acid oxidation does not potentiate systemic metabolic dysfunction.
Gonzalez-Hurtado E; Lee J; Choi J; Selen Alpergin ES; Collins SL; Horton MR; Wolfgang MJ
Am J Physiol Endocrinol Metab; 2017 May; 312(5):E381-E393. PubMed ID: 28223293
[TBL] [Abstract][Full Text] [Related]
9. Liposomes in ultrasonic drug and gene delivery.
Huang SL
Adv Drug Deliv Rev; 2008 Jun; 60(10):1167-76. PubMed ID: 18479776
[TBL] [Abstract][Full Text] [Related]
10. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles.
Colino CI; Lanao JM; Gutierrez-Millan C
Front Immunol; 2020; 11():218. PubMed ID: 32194546
[TBL] [Abstract][Full Text] [Related]
11. AMPK as a Therapeutic Target for Treating Metabolic Diseases.
Day EA; Ford RJ; Steinberg GR
Trends Endocrinol Metab; 2017 Aug; 28(8):545-560. PubMed ID: 28647324
[TBL] [Abstract][Full Text] [Related]
12. Polymersome-based drug-delivery strategies for cancer therapeutics.
Anajafi T; Mallik S
Ther Deliv; 2015; 6(4):521-34. PubMed ID: 25996048
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicines for dysfunctional macrophage-associated diseases.
He H; Ghosh S; Yang H
J Control Release; 2017 Feb; 247():106-126. PubMed ID: 28057522
[TBL] [Abstract][Full Text] [Related]
14. Active Nano-targeting of Macrophages.
Gaspar N; Zambito G; Löwik CMWG; Mezzanotte L
Curr Pharm Des; 2019; 25(17):1951-1961. PubMed ID: 31291874
[TBL] [Abstract][Full Text] [Related]
15. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics.
Dahlman JE; Kauffman KJ; Xing Y; Shaw TE; Mir FF; Dlott CC; Langer R; Anderson DG; Wang ET
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2060-2065. PubMed ID: 28167778
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine in macrophage function: a novel target for metabolic diseases.
Zhu X; Tang H; Yang M; Yin K
Trends Endocrinol Metab; 2023 Feb; 34(2):66-84. PubMed ID: 36586778
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of nanoparticulate systems for macrophage targeting.
Chellat F; Merhi Y; Moreau A; Yahia L
Biomaterials; 2005 Dec; 26(35):7260-75. PubMed ID: 16023200
[TBL] [Abstract][Full Text] [Related]
18. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Macrophage Polarization to Metabolic Diseases.
Komohara Y; Fujiwara Y; Ohnishi K; Shiraishi D; Takeya M
J Atheroscler Thromb; 2016; 23(1):10-7. PubMed ID: 26412584
[TBL] [Abstract][Full Text] [Related]
20. Macrophage Polarization: Implications on Metabolic Diseases and the Role of Exercise.
Silveira LS; Antunes Bde M; Minari AL; Dos Santos RV; Neto JC; Lira FS
Crit Rev Eukaryot Gene Expr; 2016; 26(2):115-32. PubMed ID: 27480774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
